The HARMONY Alliance, comprised of the IMI HARMONY and HARMONY PLUS projects, covers the full spectrum of research into hematologic neoplasms and seeks to facilitate the development of more effective treatments for patients affected by this type of disease

The Alliance is applying advanced analytical technologies, big data and artificial intelligence, developed by GMV, to draw the first European map of blood tumors

The HARMONY database will use the data shared to date and aims to function as a tool for designing new clinical tests and reduce their costs, with the corresponding benefits to society

GMV’s inhouse development uTile now makes it possible for information on cancer patients to be shared without jeopardizing their privacy during research into new drugs and treatment

Hospitals, research centers and the pharmaceutical industry can now strike the right balance between harnessing healthcare data and respecting patient privacy, without exposing patient data to any risk of disclosure or even moving it from the respective health center

Apex hails the firm as an innovating company on the strength of its radiosurgery planner Radiance™

The worldwide intraoperative radiation therapy market, growing at a rate of 7% from 2019 a 2024, will be worth 67.8 million dollars by the end of that period